Jones & Bartlett Learning Medicine Blog

    Hepatitis C Vaccine on the Horizon

    Posted by admin on Mar 7, 2011 12:28:10 PM

    A new vaccine being developed by a team of researchers from the University of Copenhagen in Denmark may reduce the number of positive hepatitis C tests in the future. They are reporting one of the first successful trials in inoculating animals against the disease.

    The hepatitis C virus (HCV) infects at least 170 million people worldwide and about 4 million people in the United States. It is a big public health problem because most acute hepatitis C infections become chronic which can lead to further liver problems like cirrhosis and cancer.

    "The hepatitis C virus (HCV) has the same infection pathways as HIV," says Jan Pravsgaard Christensen, Associate Professor of Infection Immunology at the Faculty of Health Sciences, University of Copenhagen.

    "Approximately one newly infected patient in five has an immune system capable of defeating an acute HCV infection in the first six months. But most cases do not present any symptoms at all and the virus becomes a chronic infection of the liver."

    Read More

    Topics: hepatitis, immunization, Infectious Disease, Prescribing, research, vaccine

    Subscribe to Blog Email Updates

    Recent Posts

    Posts by Topic

    see all